Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Conray, Cysto-conray, Glofil-125
Synonyms :
iothalamic acid
Class :
Iodine-containing radiocontrast agents
Dosage Forms & StrengthsÂ
Injection solution  Â
20%Â Â
30%Â Â
Administer usual dose is 0.5 to 2 mL/kg daily
Not determined Â
Refer to adult dosingÂ
may increase the adverse effect of metformin
they decrease the efficacy of sodium iodide I-131 iodinated contrast agents
they decrease the efficacy of sodium iodide I-131 iodinated contrast agents
they decrease the efficacy of sodium iodide I-131
may have an increased nephrotoxic effect when combined with iodinated agents
may have an increased nephrotoxic effect when combined with iodinated agents
may have an increased nephrotoxic effect when combined with iodinated agents
May have an increased hypersensitivity or allergic reactions when combined with Iodinated Agents
May have an increased nephrotoxic effect when combined with Iodinated Agents
May have an increased nephrotoxic effect when combined with Iodinated Agents
May have an increased nephrotoxic effect when combined with Iodinated Agents
aceclofenac: it may decrease the excretion rate of iothalamic acid
acemetacin: it may decrease the excretion rate of iothalamic acid
aceclofenac: it may decrease the excretion rate of iothalamic acid
acetazolamide: it may decrease the excretion rate of iothalamic acid
aclidinium: it may decrease the excretion rate of iothalamic acid
alclofenac: it may decrease the excretion rate of iothalamic acid
aldesleukin: it may decrease the excretion rate of iothalamic acid
allopurinol: it may decrease the excretion rate of iothalamic acid
almotriptan: it may decrease the excretion rate of iothalamic acid
alogliptin: it may decrease the excretion rate of iothalamic acid
bacitracin: it may decrease the excretion rate of iothalamic acid
baclofen: it may decrease the excretion rate of iothalamic acid
balsalazide: it may decrease the excretion rate of iothalamic acid
baricitinib: it may decrease the excretion rate of iothalamic acid
bisoxatin: it may decrease the excretion rate of iothalamic acid
brivaracetam: it may decrease the excretion rate of iothalamic acid
bromazepam: it may decrease the excretion rate of iothalamic acid
budesonide: it may decrease the excretion rate of iothalamic acid
Iodinated Contrast Agents may increase the adverse/toxic effect of Metformin
they increase the toxicity of saxagliptin/metformin
Actions and SpectrumÂ
iothalamic acid is a radiocontrast agent, which means it contains a substance that absorbs X-rays and enhances the visibility of certain body structures during imaging procedures. Â
It works by increasing the contrast between different tissues and fluids in the body, making it easier for radiologists and medical professionals to identify and analyse specific areas of interest.
Frequency not defined Â
NoneÂ
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
iothalamic acid’s mechanism of action is based on its high atomic number due to the iodine content. Â
iothalamic acid absorbs X-rays more effectively than surrounding tissues, creating a contrast between the structures filled with the contrast agent and the surrounding tissues. Â
PharmacodynamicsÂ
The primary pharmacodynamic effect of iothalamic acid is its ability to absorb X-rays and increase the contrast between different tissues in the body. Â
This effect is due to the high atomic number of iodine, which allows iothalamic acid to attenuate X-rays more effectively than surrounding tissues. Â
PharmacokineticsÂ
Absorption  Â
iothalamic acid is absorbed from the gastrointestinal tract into the bloodstream. Â
DistributionÂ
iothalamic acid is distributed throughout the body via the bloodstream. Â
MetabolismÂ
iothalamic acid undergoes minimal metabolism in the body. Â
Elimination and excretionÂ
iothalamic acid is primarily excreted by the kidneys.Â
AdministrationÂ
iothalamic acid is administered rectally or intravenously.
Patient information leafletÂ
Generic Name: iothalamic acidÂ
Why do we use iothalamic acid?Â
iothalamic acid can also be used in joint imaging procedures, such as arthrography. Â
iothalamic acid is indicated for evaluation of glomerular filtration and in the diagnosis of people with kidney disease.Â